checkAd
    Startseite > Aktien > RxSight > Nachrichten
    RxSight Aktie
    64,29
     
    USD
    +6,78 %
    +4,08 USD
    Letzter Kurs 02:00:00 Nasdaq
    64,29
     
    USD
    400 STK
    Geldkurs 15.05.24
    64,37
     
    USD
    400 STK
    Briefkurs 15.05.24
    ISIN: US78349D1072 · WKN: A3CWDW · SYM: RXST · USA

    Neueste Nachrichten

    RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
    13.05.24 · globenewswire · RxSight
    RxSight, Inc. Announces Pricing of Public Offering of Common Stock
    09.05.24 · globenewswire · RxSight
    RxSight, Inc. Announces Proposed Public Offering of Common Stock
    08.05.24 · globenewswire · RxSight
    RxSight, Inc. Reports First Quarter 2024 Financial Results
    06.05.24 · globenewswire · RxSight
    RxSight, Inc. to Present at the Bank of America Healthcare Conference
    01.05.24 · globenewswire · RxSight
    RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
    22.04.24 · globenewswire · RxSight
    RxSight Announces Commercial Launch of its Newest Light Adjustable Lens, the LAL+, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
    04.04.24 · globenewswire · RxSight
    RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
    27.03.24 · globenewswire · RxSight
    RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
    01.03.24 · globenewswire · RxSight
    RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
    28.02.24 · globenewswire · RxSight
    RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 
    14.02.24 · globenewswire · RxSight
    RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
    07.01.24 · globenewswire · RxSight